
Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025
Description
Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on severe acute respiratory-syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for severe acute respiratory-syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The severe acute respiratory-syndrome treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Drug Class: Antibiotics; Antiviral; Corticosteroids; Monoclonal Antibodies; Other Drug Classes
2) By Route Of Administration: Oral; Intravenous
3) By Indication: Severe Acute Respiratory Syndrome COVID-19 (SARS-CoV); Severe Acute Respiratory Syndrome COVID-19 2 (SARS‑CoV‑2)
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics
2) By Antiviral: Nucleoside Analogs; Protease Inhibitors
3) By Corticosteroids: Systemic Corticosteroids; Inhaled Corticosteroids
4) By Monoclonal Antibodies: Neutralizing Antibodies; Non-Neutralizing Antibodies
5) By Other Drug Classes: Immunomodulators; Supportive Medications
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck And Co Inc.; Novartis AG; Bristol Myers Squib company; GlaxoSmithKline plc; AstraZeneca plc; Sanofi SA; Eli Lilly And Company; Gilead Sciences Inc.; Amgen Inc.; Johnson And Johnson Private Limited; Moderna Inc.; Regeneron Pharmaceuticals Inc.; Hetero labs Ltd.; Alexion Pharmaceuticals Inc.; Cadila healthcare Ltd.; Genentech Inc.; Cipla Ltd.; Biogen Inc.; Vir Biotechnology Inc.; Swedish Orphan Biovitrum AB; Dynavax Technologies Corporation; ViiV Healthcare Limited; Panacea Biotec Limited; CureVac N.V.; CN Bio Innovations Ltd.; Inovio Pharmaceuticals Inc.; Chimerix Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on severe acute respiratory-syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for severe acute respiratory-syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The severe acute respiratory-syndrome treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Drug Class: Antibiotics; Antiviral; Corticosteroids; Monoclonal Antibodies; Other Drug Classes
2) By Route Of Administration: Oral; Intravenous
3) By Indication: Severe Acute Respiratory Syndrome COVID-19 (SARS-CoV); Severe Acute Respiratory Syndrome COVID-19 2 (SARS‑CoV‑2)
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics
2) By Antiviral: Nucleoside Analogs; Protease Inhibitors
3) By Corticosteroids: Systemic Corticosteroids; Inhaled Corticosteroids
4) By Monoclonal Antibodies: Neutralizing Antibodies; Non-Neutralizing Antibodies
5) By Other Drug Classes: Immunomodulators; Supportive Medications
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck And Co Inc.; Novartis AG; Bristol Myers Squib company; GlaxoSmithKline plc; AstraZeneca plc; Sanofi SA; Eli Lilly And Company; Gilead Sciences Inc.; Amgen Inc.; Johnson And Johnson Private Limited; Moderna Inc.; Regeneron Pharmaceuticals Inc.; Hetero labs Ltd.; Alexion Pharmaceuticals Inc.; Cadila healthcare Ltd.; Genentech Inc.; Cipla Ltd.; Biogen Inc.; Vir Biotechnology Inc.; Swedish Orphan Biovitrum AB; Dynavax Technologies Corporation; ViiV Healthcare Limited; Panacea Biotec Limited; CureVac N.V.; CN Bio Innovations Ltd.; Inovio Pharmaceuticals Inc.; Chimerix Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Self-Administered Parenteral Market Characteristics
- 3. Self-Administered Parenteral Market Trends And Strategies
- 4. Self-Administered Parenteral Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Self-Administered Parenteral Growth Analysis And Strategic Analysis Framework
- 5.1. Global Self-Administered Parenteral PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Self-Administered Parenteral Market Growth Rate Analysis
- 5.4. Global Self-Administered Parenteral Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Self-Administered Parenteral Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Self-Administered Parenteral Total Addressable Market (TAM)
- 6. Self-Administered Parenteral Market Segmentation
- 6.1. Global Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pre-Filled Syringes
- Autoinjectors
- Pen Injectors
- Other Products
- 6.2. Global Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Disposable
- Reusable
- 6.3. Global Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Online Pharmacies
- Home Healthcare Providers
- Specialty Clinics
- Other Distribution Channels
- 6.4. Global Self-Administered Parenteral Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cardiovascular Diseases
- Diabetes
- Osteoporosis
- Pain Management
- Hormone Replacement
- Other Applications
- 6.5. Global Self-Administered Parenteral Market, Sub-Segmentation Of Pre-Filled Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Glass Pre-Filled Syringes
- Plastic Pre-Filled Syringes
- 6.6. Global Self-Administered Parenteral Market, Sub-Segmentation Of Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Disposable Autoinjectors
- Reusable Autoinjectors
- 6.7. Global Self-Administered Parenteral Market, Sub-Segmentation Of Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Insulin Pen Injectors
- Growth Hormone Pen Injectors
- Other Pen Injectors
- 6.8. Global Self-Administered Parenteral Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infusion Pumps
- Needle-Free Injectors
- Combination Devices
- 7. Self-Administered Parenteral Market Regional And Country Analysis
- 7.1. Global Self-Administered Parenteral Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Self-Administered Parenteral Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Self-Administered Parenteral Market
- 8.1. Asia-Pacific Self-Administered Parenteral Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Self-Administered Parenteral Market
- 9.1. China Self-Administered Parenteral Market Overview
- 9.2. China Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Self-Administered Parenteral Market
- 10.1. India Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Self-Administered Parenteral Market
- 11.1. Japan Self-Administered Parenteral Market Overview
- 11.2. Japan Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Self-Administered Parenteral Market
- 12.1. Australia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Self-Administered Parenteral Market
- 13.1. Indonesia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Self-Administered Parenteral Market
- 14.1. South Korea Self-Administered Parenteral Market Overview
- 14.2. South Korea Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Self-Administered Parenteral Market
- 15.1. Western Europe Self-Administered Parenteral Market Overview
- 15.2. Western Europe Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Self-Administered Parenteral Market
- 16.1. UK Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Self-Administered Parenteral Market
- 17.1. Germany Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Self-Administered Parenteral Market
- 18.1. France Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Self-Administered Parenteral Market
- 19.1. Italy Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Self-Administered Parenteral Market
- 20.1. Spain Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Self-Administered Parenteral Market
- 21.1. Eastern Europe Self-Administered Parenteral Market Overview
- 21.2. Eastern Europe Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Self-Administered Parenteral Market
- 22.1. Russia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Self-Administered Parenteral Market
- 23.1. North America Self-Administered Parenteral Market Overview
- 23.2. North America Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Self-Administered Parenteral Market
- 24.1. USA Self-Administered Parenteral Market Overview
- 24.2. USA Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Self-Administered Parenteral Market
- 25.1. Canada Self-Administered Parenteral Market Overview
- 25.2. Canada Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Self-Administered Parenteral Market
- 26.1. South America Self-Administered Parenteral Market Overview
- 26.2. South America Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Self-Administered Parenteral Market
- 27.1. Brazil Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Self-Administered Parenteral Market
- 28.1. Middle East Self-Administered Parenteral Market Overview
- 28.2. Middle East Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Self-Administered Parenteral Market
- 29.1. Africa Self-Administered Parenteral Market Overview
- 29.2. Africa Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Self-Administered Parenteral Market Competitive Landscape And Company Profiles
- 30.1. Self-Administered Parenteral Market Competitive Landscape
- 30.2. Self-Administered Parenteral Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 31. Self-Administered Parenteral Market Other Major And Innovative Companies
- 31.1. Roche Holding AG
- 31.2. Eli Lilly and Company
- 31.3. Novo Nordisk A/S
- 31.4. Becton, Dickinson and Company
- 31.5. Teva Pharmaceutical Industries Ltd.
- 31.6. Mylan N.V.
- 31.7. Terumo Corporation
- 31.8. Catalent Inc.
- 31.9. Dexcom Inc.
- 31.10. West Pharmaceutical Services Inc.
- 31.11. Gerresheimer AG
- 31.12. Biocon Limited
- 31.13. Insulet Corporation
- 31.14. Halozyme Therapeutics Inc.
- 31.15. Ypsomed AG
- 32. Global Self-Administered Parenteral Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Self-Administered Parenteral Market
- 34. Recent Developments In The Self-Administered Parenteral Market
- 35. Self-Administered Parenteral Market High Potential Countries, Segments and Strategies
- 35.1 Self-Administered Parenteral Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Self-Administered Parenteral Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Self-Administered Parenteral Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.